Helen of Troy Limited said that it was “disappointed” in the outcome of a jury trial between Kaz USA, Inc., an operating subsidiary of Helen of Troy, and Exergen Corporation, headquartered in Watertown, MA, involving a thermometer patent infringement dispute.
The case involved claims of alleged patent infringement related to two forehead thermometer models sold by Kaz in the United States. On January 22, 2016, Helen of Troy stated that the jury found in favor of Exergen and awarded damages of $14.6 million with respect to a period of approximately seven years of sales.
In Helen of Troy’s statement, the company said that Kaz is respectful of the jury determination but is disappointed, and disagrees strongly with that determination. In addition, the company noted that the outcome of the case is not yet final, and the verdict will be subject to several post-trial motions.
The forehead thermometers involved in the case represented less than 1% of Helen of Troy’s consolidated net sales for fiscal year 2015, the company maintained.
Helen of Troy acquired Kaz in 2011. In its most recent third quarter 2016 fiscal year results, Helen of Troy Limited reported net sales revenue increased $9.8 million, or 2.3%, to $445.5 million, compared to $435.7 million in the third quarter of fiscal year 2015. The company’s net income for the third quarter was $46.8 million, or $1.63 per diluted share, compared to net income in the third quarter of fiscal year 2015 of $55.4 million, or $1.92 per diluted share. The company said its health and home categories, formerly referred to as health care and home environment, rose 5.3% in the third quarter.
Helen of Troy’s consumer portfolio of housewares, health and home, nutritional supplement and beauty products includes Oxo, Vicks, Braun, Honeywell, PUR, Febreze, SoftHeat, Revlon, Vidal Sassoon, Dr. Scholl’s, Pro Beauty Tools and Bed Head, among others.